Scientometrics
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Apr 15, 2025; 17(4): 102438
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.102438
Trends in nanomedicine for colorectal cancer treatment: Bibliometric and visualization analysis (2010-2024)
Yu-Ren Zhang, Hui-Rong Zhu, Hao-Ran Li, Yue-Lei Cheng, Sun-Hu Yang, Su-Ling Sun, Zheng Wang
Yu-Ren Zhang, Hui-Rong Zhu, Hao-Ran Li, Yue-Lei Cheng, Department of Oncology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
Sun-Hu Yang, Su-Ling Sun, Department of General Surgery, Shanghai TCM-Integrated Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200082, China
Zheng Wang, Department of Internal Medicine, Shanghai Guanghua Hospital of Integrative Medicine, The Affiliated with Shanghai University of Traditional Chinese Medicine, Shanghai 200052, China
Co-first authors: Yu-Ren Zhang and Hui-Rong Zhu.
Co-corresponding authors: Su-Ling Sun and Zheng Wang.
Author contributions: Zhang YR and Zhu HR conceptualized and designed this study, and Zhang YR and Cheng YL searched for relevant literature from web databases. Sun SL conducted a bibliometric analysis using CiteSpace (6.2R6), VOSVivewer (1.6.20), and bibliometrics (based on R 4.3.2) to create visual maps of the published literature, including countries, institutions, authors, keywords, and references. Wang Z proposed the research direction and wrote the preliminary manuscript. Zhang YR, Sun SL and Li HR wrote the manuscript. Sun SL revised the manuscript for grammar and cross-checked the references. Yang SH provided comments on our manuscript. Zhang YR and Zhu HR made crucial and indispensable contributions to the completion of the manuscript and are, therefore, eligible to be co-first authors of the paper. Sun SL guided and supervised the research project and revised and submitted earlier versions of the manuscript. The collaboration between Sun SL and Wang Z was crucial for the publication of this manuscript.
Supported by Shanghai Municipal Health Commission Research Project, No. 202340156.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Zheng Wang, Department of Internal Medicine, Shanghai Guanghua Hospital of Integrative Medicine, The Affiliated with Shanghai University of Traditional Chinese Medicine, No. 568 Xinhua Road, Shanghai 200052, China. willip@126.com
Received: October 18, 2024
Revised: December 25, 2024
Accepted: February 5, 2025
Published online: April 15, 2025
Processing time: 159 Days and 2.8 Hours
Core Tip

Core Tip: This study applied bibliometric analysis to track the evolution and trends in nanomedicine for colorectal cancer from 2010 to 2024. It identified China as the leading publishing country, highlighted the pivotal role of the Chinese Academy of Sciences, and underscored the surge in research post-2010. The analysis pinpoints “nanoparticles” and “drug delivery” as the dominant themes, suggesting that future research should address nanomaterial stability and targeted drug release to enhance therapeutic efficacy.